MD HB584 | 2017 | Regular Session
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 23-14)
Status: Passed on May 25 2017 - 100% progression
Action: 2017-05-25 - Approved by the Governor - Chapter 771
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Slight Partisan Bill (Democrat 23-14)
Status: Passed on May 25 2017 - 100% progression
Action: 2017-05-25 - Approved by the Governor - Chapter 771
Text: Latest bill text (Chaptered) [PDF]
Summary
Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; requiring a manufacturer of an investigational drug, biological product, or device to notify a specified patient and a specified health care provider of specified side effects or risks; requiring the Office of the Attorney General to develop an informed consent form that meets specified requirements; etc.
Title
Investigational Drugs, Biological Products, and Devices - Right to Try Act
Sponsors
Roll Calls
2017-04-02 - House - House Floor - Third Reading Passed (140-0) (Y: 140 N: 0 NV: 1 Abs: 0) [PASS]
2017-04-01 - Senate - Senate Floor - Third Reading Passed (46-0) (Y: 46 N: 0 NV: 0 Abs: 1) [PASS]
2017-03-17 - House - House Floor - Third Reading Passed (139-0) (Y: 139 N: 0 NV: 1 Abs: 1) [PASS]
2017-04-01 - Senate - Senate Floor - Third Reading Passed (46-0) (Y: 46 N: 0 NV: 0 Abs: 1) [PASS]
2017-03-17 - House - House Floor - Third Reading Passed (139-0) (Y: 139 N: 0 NV: 1 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2017-05-25 | House | Approved by the Governor - Chapter 771 |
| 2017-04-10 | House | Passed Enrolled |
| 2017-04-10 | House | Third Reading Passed (140-0) |
| 2017-04-10 | House | House Concur - Senate Amendments |
| 2017-04-07 | Senate | Third Reading Passed with Amendments (46-0) |
| 2017-04-06 | Senate | Second Reading Passed with Amendments |
| 2017-04-06 | Senate | Favorable with Amendments {967271/1 Report Adopted |
| 2017-04-06 | Senate | Favorable with Amendments Report by Finance |
| 2017-04-04 | Senate | Hearing 4/04 at 1:00 p.m. |
| 2017-03-20 | Senate | First Reading Finance |
| 2017-03-20 | House | Third Reading Passed (139-0) |
| 2017-03-17 | House | Second Reading Passed with Amendments |
| 2017-03-17 | House | Favorable with Amendments {146788/1 Report Adopted |
| 2017-03-16 | House | Favorable with Amendments Report by Health and Government Operations |
| 2017-03-02 | House | Hearing 3/02 at 1:00 p.m. |
| 2017-02-03 | House | Hearing canceled |
| 2017-02-10 | House | Hearing 2/10 at 1:00 p.m. |
| 2017-01-30 | House | First Reading Health and Government Operations |
Subjects
Attorney General
Committees and Commissions
Death
Disclosure
Diseases
Drugs
Equipment
Estates and Trusts
Health and Mental Hygiene, Department of
Health Insurance
Health Occupations
Hospices
Industry and Technology
Insurance - Health
Licenses
Medical Assistance
Medical Research
Patients
Physicians
Public Employees
Public Health
Public Officials
Committees and Commissions
Death
Disclosure
Diseases
Drugs
Equipment
Estates and Trusts
Health and Mental Hygiene, Department of
Health Insurance
Health Occupations
Hospices
Industry and Technology
Insurance - Health
Licenses
Medical Assistance
Medical Research
Patients
Physicians
Public Employees
Public Health
Public Officials
